Evidence map›Paper›PMID 37987016›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Investigation of the genetic aetiology of Lewy body diseases with and without dementia.

Lesley Wu, Raquel Real, Alejandro Martinez, Ruth Chia, Michael A Lawton, Maryam Shoai, Catherine Bresner, Leon Hubbard, Cornelis Blauwendraat, Andrew B Singleton and 10 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 4 countries.

Lesley WuDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID 0000-0001-5464-5603
Raquel RealDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID 0000-0001-8117-742X
Alejandro MartinezDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID 0000-0001-6191-1703
Ruth ChiaNeuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID 0000-0002-4709-7423
Michael A LawtonPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK.ORCID 0000-0002-3419-0354
Maryam ShoaiAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.ORCID 0000-0003-2499-8533
Catherine BresnerInstitute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff CF24 4HQ, UK.ORCID 0000-0003-2673-9762
Leon HubbardInstitute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff CF24 4HQ, UK.ORCID 0000-0002-0064-6755
Cornelis BlauwendraatIntegrative Neurogenomics Unit, National Institute on Aging, Bethesda, MD, USA.ORCID 0000-0001-9358-8111
Andrew B SingletonCenter for Alzheimer's and Related Dementias, National Institute on Aging, Bethesda, MD, USA.ORCID 0000-0001-5606-700X
Mina RytenAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.ORCID 0000-0001-9520-6957
Sonja W ScholzNeurodegenerative Diseases Research Unit, Laboratory of Neurogenetics, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.ORCID 0000-0002-6623-0429
Bryan J TraynorNeuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID 0000-0003-0527-2446
Nigel WilliamsInstitute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff CF24 4HQ, UK.ORCID 0000-0003-1177-6931
Michele T M HuNuffield Department of Clinical Neurosciences, Division of Clinical Neurology, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0001-6382-5841
Yoav Ben-ShlomoPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK.ORCID 0000-0001-6648-3007
Donald G GrossetSchool of Neuroscience and Psychology, University of Glasgow, Glasgow G51 4TF, UK.ORCID 0000-0002-2757-8203
John HardyAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.ORCID 0000-0002-3122-0423
Huw R MorrisDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID 0000-0002-5473-3774
International LBD Genomic Consortium
National Hospital for Neurology and Neurosurgery · GBCardiff University · GBNational Institute on Aging · USJohns Hopkins University · USUniversity of Bristol · GBGreat Ormond Street Hospital · GBHong Kong University of Science and Technology · HKUK Dementia Research Institute · GBUniversity of Glasgow · GBUniversity of Oxford · GB

Funding

NINDS Biomarker RepositoryU24NS095871 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI TATIANA M. FOROUD · 2015 to 2026
$18.3M
Medical Research Council MR/T018569/1NINDS NIH HHS U24 NS095871Parkinson's UK H-1703
6 · The paper itself

Abstract

Up to 80% of Parkinson's disease patients develop dementia, but time to dementia varies widely from motor symptom onset. Dementia with Lewy bodies presents with clinical features similar to Parkinson's disease dementia, but cognitive impairment precedes or coincides with motor onset. It remains controversial whether dementia with Lewy bodies and Parkinson's disease dementia are distinct conditions or represent part of a disease spectrum. The biological mechanisms underlying disease heterogeneity, in particular the development of dementia, remain poorly understood, but will likely be key to understanding disease pathways and ultimately therapy development. Previous genome-wide association studies in Parkinson's disease and dementia with Lewy bodies/Parkinson's disease dementia have identified risk loci differentiating patients from controls. We collated data for 7,804 patients of European ancestry from Tracking Parkinson's (PRoBaND), The Oxford Discovery Cohort, and AMP-PD. We conducted a discrete phenotype genome-wide association studies comparing Lewy body diseases with and without dementia to decode disease heterogeneity by investigating the genetic drivers of dementia in Lewy body diseases. We found that risk alleles rs429358 tagging

Indexed as

dementiagenome-wide association studiesLewy body diseases

Identifiers

PMID37987016
PMCPMC10659505
OpenAlexW4387736379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.